EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The QseB response regulator imparts tolerance to positively charged antibiotics by controlling metabolism and minor changes to LPS

Melanie N Hurst, Connor J Beebout, Alexis Hollingsworth, Kirsten R Guckes, Alexandria Purcell, Tomas A Bermudez, Diamond Williams, Seth A Reasoner, M Stephen Trent iD, Maria Hadjifrangiskou iD

mSphere · 2023

DOI: 10.1128/msphere.00059-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2023. Verfasst von Melanie N Hurst und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center , Nashville, Tennessee, …. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Escherichia coli Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The modification of lipopolysaccharide (LPS) in Escherichia coli and Salmonella spp. is primarily controlled by the two-component system PmrAB. LPS modification allows bacteria to avoid killing by positively charged antibiotics like polymyxin B (PMB). We previously demonstrated that in uropathogenic E. coli (UPEC), the sensor histidine kinase PmrB also activates a non-cognate transcription factor, QseB, and this activation somehow augments PMB tolerance in UPEC. Here, we demonstrate—for the first time—that in the absence of the canonical LPS transcriptional regulator, PmrA, QseB can direct some modifications on the LPS. In agreement with this observation, transcriptional profiling analyses demonstrate regulatory overlaps between PmrA and QseB in terms of regulating LPS modification genes. However, both PmrA and QseB must be present for UPEC to mount robust tolerance to PMB. Transcriptional and metabolomic analyses also reveal that QseB transcriptionally regulates the metabolism of glutamate and 2-oxoglutarate, which are consumed and produced during the modification of lipid A. We show that deletion of qseB alters glutamate levels in the bacterial cells. The qseB deletion mutant, which is susceptible to positively charged antibiotics, is rescued by exogenous addition of 2-oxoglutarate. These findings uncover a previously unknown mechanism of metabolic control of antibiotic tolerance that may be contributing to antibiotic treatment failure in the clinic. IMPORTANCE Although antibiotic prescriptions are guided by well-established susceptibility testing methods, antibiotic treatments oftentimes fail. The presented work is significant because it uncovers a mechanism by which bacteria transiently avoid killing by antibiotics. This mechanism involves two closely related transcription factors, PmrA and QseB, which are conserved across Enterobacterales . We demonstrate that PmrA and QseB share regulatory targets in lipid A modification pathway and prove that QseB can orchestrate modifications of lipid A in Escherichia coli in the absence of PmrA. Finally, we show that QseB controls glutamate metabolism during the antibiotic response. These results suggest that rewiring of QseB-mediated metabolic genes could lead to stable antibiotic resistance in subpopulations within the host, thereby contributing to antibiotic treatment failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsEscherichia coli ProteinsLipopolysaccharidesEscherichia coliBacterial ProteinsLipid AKetoglutaric AcidsPolymyxin BTranscription FactorsGlutamates

Stichwörter der Autor:innen

QseBUPECamino acid metabolismantibioticstolerance

Substanzen

Anti-Bacterial AgentsLipopolysaccharidesBacterial ProteinsLipid AKetoglutaric AcidsPolymyxin BTranscription FactorsGlutamatesQseB protein, E coliEscherichia coli Proteins

Autor:innen und Institutionen

  • Division of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center , Nashville, Tennessee, USA.
  • Department of Biological Sciences, Vanderbilt University , Nashville, Tennessee, USA.
  • Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia , Athens, Georgia, USA.
  • Vanderbilt Institute for Infection, Immunology and Inflammation , Nashville, Tennessee, USA.
  • Center for Personalized Microbiology, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center , Nashville, Tennessee, USA.

ORCID-Profile: M Stephen Trent, Maria Hadjifrangiskou

Förderung

  • NIAID NIH HHS
  • NIDDK NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Hurst, M. N., Beebout, C. J., Hollingsworth, A., Guckes, K. R., Purcell, A., Bermudez, T. A., Williams, D., Reasoner, S. A., Trent, M. S., & Hadjifrangiskou, M. (2023). The QseB response regulator imparts tolerance to positively charged antibiotics by controlling metabolism and minor changes to LPS. mSphere. https://doi.org/10.1128/msphere.00059-23

Vancouver

Hurst MN, Beebout CJ, Hollingsworth A, Guckes KR, Purcell A, Bermudez TA, et al. The QseB response regulator imparts tolerance to positively charged antibiotics by controlling metabolism and minor changes to LPS. mSphere. 2023. doi:10.1128/msphere.00059-23

BibTeX
@article{Hurst2023,
  author = {Hurst, Melanie N and Beebout, Connor J and Hollingsworth, Alexis and Guckes, Kirsten R and Purcell, Alexandria and Bermudez, Tomas A and Williams, Diamond and Reasoner, Seth A and Trent, M Stephen and Hadjifrangiskou, Maria},
  title = {The QseB response regulator imparts tolerance to positively charged antibiotics by controlling metabolism and minor changes to LPS},
  journal = {mSphere},
  year = {2023},
  doi = {10.1128/msphere.00059-23}
}
Kostenlos starten →